The inflammatory response and cardiac repair after myocardial infarction
- PMID: 19949583
- PMCID: PMC2771790
- DOI: 10.4070/kcj.2009.39.10.393
The inflammatory response and cardiac repair after myocardial infarction
Abstract
One of the most important therapeutic targets of current cardiology practice is to determine optimal strategies for the minimization of myocardial necrosis and optimization of cardiac repair following an acute myocardial infarction. Myocardial necrosis after acute myocardial infarction induces complement activation and free radical generation, triggering a cytokine cascade initiated by tumor necrosis factor-alpha (TNF-alpha) release. When reperfusion of the infarcted area is initiated, intense inflammation follows. Chemokines, cytokines and the complement system play an important role in recruiting neutrophils in the ischemic and reperfused myocardium. Cytokines promote adhesive interactions between leukocytes and endothelial cells, resulting in transmigration of inflammatory cells into the site of injury. The recruited neutrophils have potent cytotoxic effects through the release of proteolytic enzymes, and they interact with adhesion molecules on cardiomyocytes. In spite of the potential injury, reperfusion enhances cardiac repair; this may be related to the inflammatory response. Monocyte chemoattractant protein (MCP)-1 is upregulated in reperfused myocardium and can induce monocyte recruitment in the infarcted area. Monocyte subsets play a role in phagocytosis of dead cardiomyocytes and in granulation tissue formation. In addition, the transforming growth factor (TGF)-beta plays a crucial role in cardiac repair by suppressing inflammation. Resolution of inflammatory infiltration, containment of inflammation and the reparative response affecting the infarcted area are essential for optimal infarct healing. Here, we review the current literature on the inflammatory response and cardiac repair after myocardial infarction.
Keywords: Cytokines; Inflammation; Left ventricle remodeling; Myocardial infarction.
Figures
Similar articles
-
The inflammatory response in myocardial infarction.Cardiovasc Res. 2002 Jan;53(1):31-47. doi: 10.1016/s0008-6363(01)00434-5. Cardiovasc Res. 2002. PMID: 11744011 Review.
-
The immune system and cardiac repair.Pharmacol Res. 2008 Aug;58(2):88-111. doi: 10.1016/j.phrs.2008.06.007. Epub 2008 Jun 24. Pharmacol Res. 2008. PMID: 18620057 Free PMC article. Review.
-
Inflammatory mechanisms in myocardial infarction.Curr Drug Targets Inflamm Allergy. 2003 Sep;2(3):242-56. doi: 10.2174/1568010033484098. Curr Drug Targets Inflamm Allergy. 2003. PMID: 14561159 Review.
-
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Circ Res. 2016 Jun 24;119(1):91-112. doi: 10.1161/CIRCRESAHA.116.303577. Circ Res. 2016. PMID: 27340270 Free PMC article. Review.
-
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling.Cardiovasc Res. 2007 May 1;74(2):313-22. doi: 10.1016/j.cardiores.2006.11.028. Epub 2006 Nov 23. Cardiovasc Res. 2007. PMID: 17188669 Free PMC article.
Cited by
-
Removal of epicardial adipose tissue after myocardial infarction improves cardiac function.Herz. 2018 May;43(3):258-264. doi: 10.1007/s00059-017-4555-4. Epub 2017 Apr 4. Herz. 2018. PMID: 28378031 English.
-
Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro.Inflammation. 2013 Jun;36(3):592-602. doi: 10.1007/s10753-012-9581-z. Inflammation. 2013. PMID: 23269534
-
Network Pharmacology Approaches to Myocardial Infarction Reperfusion Injury: Exploring Mechanisms, Pathophysiology, and Novel Therapies.Biomedicines. 2025 Jun 23;13(7):1532. doi: 10.3390/biomedicines13071532. Biomedicines. 2025. PMID: 40722608 Free PMC article. Review.
-
Vitamin D inflammatory cytokines and coronary events: a comprehensive review.Clin Rev Allergy Immunol. 2013 Oct;45(2):236-47. doi: 10.1007/s12016-013-8356-0. Clin Rev Allergy Immunol. 2013. PMID: 23314982 Clinical Trial.
-
Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.Int J Cardiol. 2013 Sep 10;167(6):2638-45. doi: 10.1016/j.ijcard.2012.06.127. Epub 2012 Jul 19. Int J Cardiol. 2013. PMID: 22818386 Free PMC article.
References
-
- Jennings RB, Murry CE, Steenbergen C, Jr, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation. 1990;82(3 Suppl):II2–II12. - PubMed
-
- Deten A, Volz HC, Briest W, Zimmer HG. Cardiac cytokine expression is upregulated in the acute phase after myocardial in farction: experimental studies in rats. Cardiovasc Res. 2002;55:329–340. - PubMed
-
- Irwin M, Mak S, Mann DL, et al. Tissue expression and immunolocalization of tumour necrosis factor-alpha in post infarction-dysfunctional myocardium. Circulation. 1999;99:1492–1498. - PubMed
-
- Birdsall HH, Green DM, Trial J, et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation. 1997;95:684–692. - PubMed
-
- Dewald O, Zymek P, Winkelmann K, et al. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881–889. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous